Why is Dr Agarwal's Hea falling/rising?
2025-11-29 01:11:33Consistent Gains Outperforming Market Benchmarks Over the past week, Dr Agarwals Health Care Ltd has delivered an impressive return of 7.77%, significantly outpacing the Sensex’s modest 0.56% gain during the same period. This strong relative performance highlights the stock’s resilience and appeal amid broader market fluctuations. Even on a monthly basis, the stock has appreciated by 2.78%, surpassing the Sensex’s 1.27% rise, signalling sustained momentum beyond short-term trading. Technical Strength Evident in Moving Averages The stock’s current price level is notably above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This technical positioning is a clear indicator of bullish sentiment among traders and investors, suggesting...
Read MoreWhy is Dr Agarwal's Hea falling/rising?
2025-11-07 00:28:26As of 06-Nov, Dr Agarwals Health Care Ltd's stock price is currently at Rs 508.60, reflecting a decrease of Rs 6.3 or 1.22%. The stock has been underperforming, having fallen for the last two days with a total decline of 2.26%. Today's performance indicates that the stock underperformed its sector by 0.57%, and it reached an intraday low of Rs 495.25, which is a drop of 3.82%. Additionally, the stock's delivery volume has decreased significantly, falling by 36.88% compared to the five-day average, suggesting a decline in investor participation. The stock's performance over the past week shows a loss of 2.06%, while it has gained 3.55% over the past month. In the broader market context, the Sensex has also experienced a decline of 1.30% over the past week, indicating that the market is facing some headwinds. However, Dr Agarwals Health Care Ltd's short-term performance is worse than the benchmark, which may...
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30-Jan-2026 | Source : BSEIntimation of Schedule of Analyst / Investors Meet is attached.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
28-Jan-2026 | Source : BSEIntimation of Analyst / Earnings Conference call to discuss the Standalone And Consolidated Unaudited Financial Results of the Company For The Quarter And Nine Months Ended December 31 2025 is attached.
Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025
28-Jan-2026 | Source : BSEDr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve the Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available